ISNCT

Category: Year 2022

Article Boron compound Chemistry In-vitro Studies Year 2022

The Mossbauer effect using Fe-57-ferrabisdicarbollide ([o-(57)FESAN](-)): a glance into the potential of a low-dose approach for glioblastoma radiotherapy

Post author By ISNCT
Post date September 27, 2022

Inorganic Chemistry Frontiers, 2022

Tags A.B. Buades, A.C. Cerdeira, A.P.A. Matos, B.J.C. Vieira, C.G. Pinto, F. Mendes, F. Teixidor and C. Viñas, Inorganic Chemistry Frontiers, J.C. Waerenborgh, J.F. Guerreiro, L.C.J. Pereira, S. Valic, T. Pinheiro

Article Boron Compounds Chemistry Small Boron compounds Year 2022

Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent

Post author By ISNCT
Post date July 25, 2022

Pharmaceutics, 2022

Tags Fuko Hirano, Naoya Kondo, Pharmaceutics, Takashi Temma

Article Mixed Therapies (BNCT + Other Therapies) Recurrences Toxicity Year 2022

Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma

Post author By ISNCT
Post date July 25, 2022

Japanese Journal of Clinical Oncology, 2022

Tags Hiroki Tanaka, Hiroyuki Shiba, Japanese Journal of Clinical Oncology, Koji Ono, Koji Takeuchi, Masahiko Wanibuchi, Minoru Suzuki, Motomasa Furuse, Natsuko Kondo, Shin-ichi Miyatake, Shinji Kawabata, Yoshinori Sakurai

Article Clinical trials Phase II Studies Toxicity Year 2022

Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study

Post author By ISNCT
Post date May 20, 2022

Journal of Radiation Research, 2022

Tags Hirose K., Journal of Radiation Research, Kato T., Kikuchi Y., Murakami M., Sato M., Seto I., Suzuki M., Takai Y., Takayama K., Yamaguchi H.